Prevention and treatment of cepharanthine through MAPK/ERK signaling pathway in rats with nasopharyngeal carcinoma and its effect on Survivin, XIAP and Bcl-2 / 西安交通大学学报(医学版)

ABSTRACT

【Objective】 To investigate the preventive and therapeutic effects of cepharanthine on nasopharyngeal carcinoma rats through the mitogen-activated protein kinase (MAPK)/extracellular signal regulated kinase (ERK) signaling pathway and its effect on Survivin and X-linked inhibitor of apoptosis protein (XIAP), and B-cell lymphoma/leukemia-2 (Bcl-2). 【Methods】 A rat model of nasopharyngeal carcinoma was established by subcutaneous injection of dinitrosopiperazine (DNP). Then the rats were randomly divided into model group, stephenine group, activator group, inhibitor group, and control group. Interleukin (IL)-1β and IL-18 levels in nasal lavage fluid were detected, HE staining was used to observe pathological changes of nasal mucosa, TUNEL method was used to observe cell apoptosis of nasal mucosa, Western blotting was used to detect ERK, p-ERK, Survivin, XIAP, Bcl-2, Bcl-2 associated X protein (Bax) protein expression of nasal mucosa. 【Results】 The histopathological changes of rat nasal mucosa in stephenine group, activator group and inhibitor group were significantly better than those in model group; the improvement in activator group was worse. Compared with model group, the body mass, Survivin, XIAP, and Bcl-2 protein expressions increased, while the levels of IL-1β and IL-18, the rate of apoptosis and p-ERK1/2 and Bax protein expressions decreased in cephalothin group, activator group and inhibitor group (P<0.05). Compared with cephalothin group, in activator group the body mass, Survivin, XIAP, and Bcl-2 protein expressions decreased, whereas IL-1β and IL-18 levels, the rate of apoptosis, and p-ERK1/2 and Bax protein expressions increased. In inhibitor group, the body mass, Survivin, XIAP, and Bcl-2 protein expressions increased, IL-1β and IL-18 levels, the rate of apoptosis, and p-ERK1/2 and Bax protein expressions decreased (P<0.05). 【Conclusion】 Stephaneine has a certain preventive effect on nasopharyngeal carcinoma rats, which may play an effect by inhibiting the MAPK/ERK pathway.